Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5640 | 0.87 | — | — | |
| SCHEMBL15869348 | 0.87 | — | — | |
| SCHEMBL10417889 | 0.87 | — | — | |
| SCHEMBL10275116 | 0.75 | — | — | |
| SCHEMBL19876982 | 0.75 | — | — | |
| Methane SCHEMBL8836373 | 0.75 | — | — | |
| SCHEMBL5859282 | 0.75 | — | — | |
| SCHEMBL11319151 | 0.75 | — | — | |
| Ammonia Solution, Strong SCHEMBL4138673 | 0.75 | — | — | |
| Bromide SCHEMBL6568202 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-9143127-A | — | — | None | — | — | JP | disclosed |
| CN-121588907-A | Preparation method of supported modified gold catalyst and application of supported modified gold catalyst in hydrochlorination of acetylene | 河北工程大学 | 2026-03-03 | — | — | CN | disclosed |
| CN-117717538-A | PH-triggered mechanical gene therapy nano drug delivery system and preparation method and application thereof | 复旦大学附属中山医院 | 2024-03-19 | — | — | CN | disclosed |
| CN-109384741-B | 3,7-diamino-10H-phenothiazine compound salt and application thereof | 维斯塔实验室有限公司 | 2023-01-06 | — | — | CN | disclosed |
| US-20220324800-A1 | SARS-3CL PROTEASE INHIBITORS | Primmune Therapeutics, Inc. | 2022-10-13 | — | — | US | disclosed |
| WO-2022212707-A1 | SARS-3CL PROTEASE INHIBITORS | Primmune Therapeutics, Inc. (US) | 2022-10-06 | — | — | WO | disclosed |
| CN-104606199-B | 3, 7-diamino-10H-phenothiazine compound salt and use thereof | 维斯塔实验室有限公司 | 2022-09-13 | — | — | CN | disclosed |
| EP-2935237-A1 | SUBSTITUTED [1,2,4]TRIAZOLE COMPOUNDS AND THEIR USE AS FUNGICIDES | BASF SE (DE) | 2015-10-28 | — | — | EP | disclosed |
| CN-104119294-A | Preparation method of 3,7-diamino-10H-phenothiazine compounds | WISTA LAB LTD | 2014-10-29 | — | — | CN | disclosed |
| WO-2014095672-A1 | SUBSTITUTED [1,2,4]TRIAZOLE COMPOUNDS AND THEIR USE AS FUNGICIDES | BASF SE (DE) | 2014-06-26 | — | — | WO | disclosed |
| US-4997950-A | Antisecretory | MURPHY RICHARD FINBAR (US) | 1991-03-05 | — | — | US | disclosed |
| CN-1011784-B | Process for preparing antiallergic and antimuscotromospasm agents N-benzhydryldiazacycloalkylalkyl anilides | RECKORDATY CHEMICALS CORP (CH) | 1991-02-27 | — | — | CN | disclosed |
| US-4680283-A | LACHRYMATORS | MERCK & CO., INC. (US) | 1987-07-14 | — | — | US | disclosed |
| CN-86105641-A | The method for preparing antianaphylaxis and antibronchospasm of N-dibenzyl-diazacyclo alkyl-alkyl-anilide | — | 1987-04-01 | — | — | CN | disclosed |
| EP-0176436-A2 | Analogs of substance P and eledoisin | MERCK & CO. INC. (US) | 1986-04-02 | — | — | EP | disclosed |
| US-4550163-A | Ligand analog-irreversible enzyme inhibitor conjugates | ABBOTT LABORATORIES (US) | 1985-10-29 | — | — | US | disclosed |
| US-4355172-A | Process for 4-(D-3-amino-3-carboxypropoxy)-phenylglyoxylic acid oxime derivatives | ELI LILLY AND COMPANY (US) | 1982-10-19 | — | — | US | disclosed |
| US-4273866-A | IMMUNOASSAY FOR QUANTITATIVE ANALYSIS OF ACETYLCHOLINESTERASE | ABBOTT LABORATORIES (US) | 1981-06-16 | — | — | US | disclosed |
| US-4215078-A | Process for manufacturing chloroprene and 2,3-dichlorobutadiene-1,3 | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1980-07-29 | — | — | US | disclosed |
| US-4211867-A | ANTISECRETORY AGENTS, HYPOGLYCEMIC AGENTS, ANTIARRHYTHMIA AGENTS | MCNEIL LABORATORIES, INCORPORATED (US) | 1980-07-08 | — | — | US | disclosed |